Patient Guide: Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 31 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07317934
Status: NOT_YET_RECRUITING
Condition: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase: PHASE3

Find a Study Location Near You

This study is available at 31 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Hefei, Anhui
  • Beijing, Beijing Municipality
  • Beijing, Beijing Municipality
  • • And 28 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily